%0 Journal Article
%T High-Dose (2.5 mg) Intravitreal Bevacizumab as Rescue Therapy for Persistent Postradiation Cystoid Macular Edema
%A Arman Mashayekhi
%A Carol L. Shields
%A Jerry A. Shields
%A Kyle Ferguson
%A Mohammed Ali Khan
%J Archive of "Ocular Oncology and Pathology".
%D 2017
%R 10.1159/000448719
%X To investigate the efficacy of intravitreal high-dose (2.5 mg/0.1 mL) bevacizumab as rescue therapy for postradiation cystoid macular edema (CME) resistant to standard-dose (1.25 mg/0.05 mL) bevacizumab
%K Tumor
%K Melanoma
%K Radiotherapy
%K Cystoid macular edema
%K Radiation damage
%K Anti-VEGF
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675124/